Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuaki Anami

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|August 19, 2016
Apo- and Antagonist-Binding Structures of Vitamin D Receptor Ligand-Binding Domain Revealed by Hybrid Approach Combining Small-Angle X-ray Scattering and Molecular DynamicsYasuaki Anami, Nobutaka Shimizu, Toru Ekimoto, et al.
RSC Advances|April 15, 2022
Homogeneous antibody-angiopep 2 conjugates for effective brain targetingYasuaki Anami, Wei Xiong, Aiko Yamaguchi, et al.
Nature Communications|June 30, 2018
Glutamic acid-valine-citrulline linkers ensure stability and efficacy of antibody-drug conjugates in miceYasuaki Anami, Chisato M Yamazaki, Wei Xiong, et al.
Bioorganic & Medicinal Chemistry|October 31, 2015
Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activityYasuaki Anami, Yuta Sakamaki, Toshimasa Itoh, et al.
Mabs|April 7, 2022
Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse modelPeng Zhao, Yasuaki Anami, Peng Gao, et al.
Organic & Biomolecular Chemistry|June 27, 2017
Enzymatic conjugation using branched linkers for constructing homogeneous antibody-drug conjugates with high potencyYasuaki Anami, Wei Xiong, Xun Gui, et al.
Molecular Cancer Therapeutics|September 4, 2020
LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid LeukemiaYasuaki Anami, Mi Deng, Xun Gui, et al.
Nature Communications|June 11, 2021
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistanceChisato M Yamazaki, Aiko Yamaguchi, Yasuaki Anami, et al.
Bioorganic & Medicinal Chemistry|January 22, 2021
Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scopeAiko Yamaguchi, Yasuaki Anami, Summer Y Y Ha, et al.
Cell Reports|May 25, 2022
Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumorsYasuaki Anami, Yoshihiro Otani, Wei Xiong, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|August 19, 2016
Apo- and Antagonist-Binding Structures of Vitamin D Receptor Ligand-Binding Domain Revealed by Hybrid Approach Combining Small-Angle X-ray Scattering and Molecular DynamicsYasuaki Anami, Nobutaka Shimizu, Toru Ekimoto, et al.
RSC Advances|April 15, 2022
Homogeneous antibody-angiopep 2 conjugates for effective brain targetingYasuaki Anami, Wei Xiong, Aiko Yamaguchi, et al.
Nature Communications|June 30, 2018
Glutamic acid-valine-citrulline linkers ensure stability and efficacy of antibody-drug conjugates in miceYasuaki Anami, Chisato M Yamazaki, Wei Xiong, et al.
Bioorganic & Medicinal Chemistry|October 31, 2015
Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activityYasuaki Anami, Yuta Sakamaki, Toshimasa Itoh, et al.
Mabs|April 7, 2022
Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse modelPeng Zhao, Yasuaki Anami, Peng Gao, et al.
Organic & Biomolecular Chemistry|June 27, 2017
Enzymatic conjugation using branched linkers for constructing homogeneous antibody-drug conjugates with high potencyYasuaki Anami, Wei Xiong, Xun Gui, et al.
Molecular Cancer Therapeutics|September 4, 2020
LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid LeukemiaYasuaki Anami, Mi Deng, Xun Gui, et al.
Nature Communications|June 11, 2021
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistanceChisato M Yamazaki, Aiko Yamaguchi, Yasuaki Anami, et al.
Bioorganic & Medicinal Chemistry|January 22, 2021
Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scopeAiko Yamaguchi, Yasuaki Anami, Summer Y Y Ha, et al.
Cell Reports|May 25, 2022
Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumorsYasuaki Anami, Yoshihiro Otani, Wei Xiong, et al.
Pageof 3